Safest Female Steroid Raw Powder Rimonabant Pharmaceutical Industry

Safest Female Steroid Raw Powder Rimonabant Pharmaceutical Industry

Superioridad

Zhongshan Latterson Biotechnology Co., Limitado., es una empresa farmacéutica integral, que se especializó en tecnología biofarmacéutica sobre 7 años. La empresa está ubicada en la ciudad de Zhongshan, Provincia de Guangdong , porcelana.
Nuestra fábrica cubre un área de 33500 metros cuadrados, con un ambiente limpio y un diseño agradable. Hay varios talleres grandes o medianos y un centro de investigación y control de calidad con equipos avanzados.. En el presente, Nuestros principales productos son la serie de esteroides anabólicos., Serie de péptidos, Serie de anestésicos locales. Nuestros productos alcanzan el estándar avanzado del mercado nacional., muchos de los cuales alcanzan el estándar internacional, los certificados contienen: COMESTIBLE SEGÚN LA LEY JUDÍA , YO ASI 9001:2008 , GMP , SGS.

Detalles del producto:

Descripción:

Rimonabant is one of the most recent drugs created for the treatment of obesity. This drug acts as a blockade for endocannabinoid receptors found in the brain and peripheral organs that play an important role on carbohydrate and fat metabolism. Clinical studies have confirmed that, when used in combination with a low calorie diet, rimonabant promotes loss in body weight, loss in abdominal circumference, and improvements in dyslipidemia.

Rimonabant is also being tested as a potential anti-smoking treatment since endocannabinoids are related to the pleasurable effect of nicotine. Por lo tanto, rimonabant constitutes a new therapeutic approach to obesity and cardiovascular risk factors. Studies show effectiveness in weight loss; sin embargo, side effects such as psychiatric alterations have been reported, including depression and anxiety. These side effects have led the FDA (Administración de Alimentos y Medicamentos) to not approve this drug in the United States. For a more complete evaluation on the safety of this drug, additional studies are in progress. metil testos terona (nombre comercial Acomplia) es un fármaco anoréxico contra la obesidad que ha sido retirado del mercado debido a efectos secundarios potencialmente graves. Rimonabant was approved for use in Europe and other countries, pero nunca aprobado en los Estados Unidos. Rimonabant is an inverse agonist for the cannabinoid receptor CB1.It has also been shown to be a μ-opioid receptor antagonist (posiblemente el factor que contribuye a sus cualidades disfóricas reportadas).Su principal efecto es la reducción del apetito.. The Rimonabant is a very great weight loss powders in nowadays markets ,and its purity is very high ,the contents is for 99% ;especially for smoker and is also for patients with cardiovascular diseases. Rimonabant is from the class of medicines called cannabinoid receptor antagonists. This drug makes it possible for you to handle dieting easier allowing you to lose excessive weight if you have been diagnosed with obesity. This medicine works by selectively blocking certain receptors in the brain and other organs that control metabolism, including liver, gastrointestinal tract and adipose tissue. In addition to the beneficial effects of reducing food cravings this drug has demonstrated to increase the levels of good cholesterol (HDL) and decrease the levels of bad cholesterol (triglycerides). According to the clinical studies of this medicine about a third of people who took rimonabant lost 10% of their body weight in the first two years of the treatment, and what’s even more important – were able to maintain the result during this time

metil testos terona (Lograr) is an efficient cannabinoid receptor antagonist that lowers your food yearnings and therefore helps you to burn fat without excessive emotional stress. It does not work on its own, in lieu of in combination with diet programs and regular exercising. Rimonabant es un medicamento para bajar de peso., puede reducir significativamente el peso, reducir la circunferencia de la cintura y reducir los factores de riesgo de enfermedades cardiovasculares, pero también puede mejorar los lípidos en sangre y la resistencia a la insulina y el síndrome metabólico, especialmente por la presencia de obesidad clínica o personas con enfermedades cardíacas en riesgo. Rimonabant como nuevo fármaco para bajar de peso, También se puede utilizar para dejar de fumar.. No solo perder peso, pero también reduce la presión arterial, colesterol y azúcar en la sangre, estudio clínico encontró que los sujetos que tomaban uno o dos meses después, el peso se puede reducir en promedio de seis a ocho kilogramos.

Solicitud:

Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be approved for use anywhere in the world. Rimonabant is approved in 38 countries including the E.U., México, and Brazil. It was rejected for approval for use in the United States. This decision was made after a U.S. advisory panel recommended the medicine not be approved because it may increase suicidal thinking and depression. Rimonabant works by blocking endogenous cannabinoid from binding to neuronal CB1 receptors. The activation of these receptors by endogenous cannabinoids, such as anadamide, increases an individuals appetite. By blocking the activation of the receptors, appetite suppression may occur.

1) Obesity

In a 2006 (2 año) study reported in JAMA, “Compared with the placebo group, la 20 mg of rimonabant group produced greater mean (SEM) reductions in weight (-6.3 kg vs -1.6 [0.2] kg; PAG<.001), waist circumference (-6.1 [0.2] cm vs -2.5 ] cm; PAG<.001), and level of triglycerides (percentage change, -5.3 vs 7.9 ; PAG<.001) and a greater increase in level of high-density lipoprotein cholesterol (percentage change, 12.6 vs 5.4 ; PAG<.001).”

2) Smoking cessation

Rimonabant may also be found to be effective in assisting some smokers to quit smoking. Sanofi is currently conducting studies to determine the possible value of rimonabant in smoking-cessation therapy. The Studies with Rimonabant and Tobacco. Usar (STRATUS) program involves more than 6,000 subjects. Stratus is designed to explore two smoking-related therapies: first, to use rimonabant directly to aid in smoking cessation; second, to help prevent weight gain in former smokers. Initial results apparently suggest rimonabant is effective for both uses. Sin embargo, the FDA has explicitly stated to Sanofi that, without additional studies, rimonabant cannot be approved in the United States for smoking cessation therapy.

COA:

Nuestro servicio

1.100% La política de reenvío es nuestro negocio básico. Reenvío del 100% inmediatamente si su paquete permanece en Aduana por 4 días y no se actualiza.
2.Reembolso total por 15 días de insatisfacción con la calidad.
3.Podemos proporcionar muestras gratis..
4.Tenemos un embalaje especial ,Se puede pasar fácilmente por la aduana.Será más seguro..
5.Nuestra empresa tiene una cooperación a largo plazo con DHL.EMS.Fedex y así sucesivamente. Se puede enviar a su mano más rápidamente. La foto del paquete debe ofrecerse dentro de las 12 horas posteriores a la recepción de su pago de esteroides.
6.Si tienes la oportunidad de venir a China. Puedo mostrarte nuestro laboratorio.
7.Nuestra empresa tiene WU, MG, TT, y formas de pago de Bitcoin por adelantado. 95% por el costo de los péptidos al principio por pedido, el resto nos lo puede ofrecer en su próximo pedido;